Sign In
Buy ANAB
$51.24
-0.0200 (-0.0390%)
At Close: Jun 03, 2026
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
03:30pm, Wednesday, 10'th Jun 2020
Is (ANAB) Outperforming Other Medical Stocks This Year?
Rhumbline Advisers Buys 622 Shares of AnaptysBio Inc (NASDAQ:ANAB)
04:21am, Wednesday, 10'th Jun 2020
Rhumbline Advisers lifted its stake in AnaptysBio Inc (NASDAQ:ANAB) by 1.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The in
Here's Why AnaptysBio Rose 22.1% in May
10:09pm, Tuesday, 09'th Jun 2020
The beaten-up biopharma stock trekked higher after the development-stage company delivered a slew of pipeline updates alongside first quarter 2020 operating results. The small-cap stock has now gaine
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB
11:33am, Wednesday, 27'th May 2020
Pomerantz LLP is investigating claims on behalf of investors AnaptysBio, Inc. (“AnaptysBio” or the “Company”) (ANAB). Such investors are advised to contact Robert S. Willoughby at rswilloughb
SHAREHOLDER ALERT: ANAB HAFC WORX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
04:40pm, Tuesday, 26'th May 2020
NEW YORK, NY / ACCESSWIRE / May 26, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a lo
LOS ANGELES, CA / ACCESSWIRE / May 26, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AnaptysBio, Inc. ("AnaptysBio"
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, MESA and GSX
02:50pm, Tuesday, 26'th May 2020
NEW YORK, NY / ACCESSWIRE / May 26, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. S
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The Complaint alleges that throughout th
Los Angeles, California--(Newsfile Corp. - May 26, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AnaptysBio, Inc. (
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have only until May 26, 2020 to file lead plaintiff applicati
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, SERV and CONN
07:50pm, Monday, 25'th May 2020
NEW YORK, NY / ACCESSWIRE / May 25, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. S
LOS ANGELES / ACCESSWIRE / May 25, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against AnaptysBio, Inc. ("AnaptysBio" or "
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AnaptysBio, Inc. - ANAB
06:20pm, Monday, 25'th May 2020
NEW YORK, NY / ACCESSWIRE / May 25, 2020 / Pomerantz LLP is investigating claims on behalf of investors AnaptysBio, Inc. ("AnaptysBio" or the "Company") (ANAB). Such investors are advised to contact
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. The Complaint alleges that throughout th
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
03:30pm, Monday, 25'th May 2020
Is (ANAB) Outperforming Other Medical Stocks This Year?
